X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SANOFI INDIA ALKEM LABORATORIES/
SANOFI INDIA
 
P/E (TTM) x - 30.5 - View Chart
P/BV x 6.1 5.4 114.2% View Chart
Dividend Yield % 0.7 1.7 42.1%  

Financials

 ALKEM LABORATORIES   SANOFI INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
SANOFI INDIA
Dec-16
ALKEM LABORATORIES/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,5894,560 34.8%   
Low Rs1,2324,400 28.0%   
Sales per share (Unadj.) Rs417.51,028.5 40.6%  
Earnings per share (Unadj.) Rs56.3129.0 43.7%  
Cash flow per share (Unadj.) Rs64.7186.0 34.8%  
Dividends per share (Unadj.) Rs12.7068.00 18.7%  
Dividend yield (eoy) %0.91.5 59.3%  
Book value per share (Unadj.) Rs292.9753.6 38.9%  
Shares outstanding (eoy) m119.5723.03 519.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.4 77.6%   
Avg P/E ratio x25.134.7 72.1%  
P/CF ratio (eoy) x21.824.1 90.5%  
Price / Book Value ratio x4.85.9 81.0%  
Dividend payout %22.652.7 42.8%   
Avg Mkt Cap Rs m168,653103,174 163.5%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m9,1713,592 255.3%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m49,91523,686 210.7%  
Other income Rs m1,645708 232.4%   
Total revenues Rs m51,56124,394 211.4%   
Gross profit Rs m8,4825,281 160.6%  
Depreciation Rs m1,0061,313 76.6%   
Interest Rs m67115 4,470.7%   
Profit before tax Rs m8,4514,661 181.3%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6061,691 95.0%   
Profit after tax Rs m6,7312,970 226.6%  
Gross profit margin %17.022.3 76.2%  
Effective tax rate %19.036.3 52.4%   
Net profit margin %13.512.5 107.5%  
BALANCE SHEET DATA
Current assets Rs m27,06215,673 172.7%   
Current liabilities Rs m15,3246,678 229.5%   
Net working cap to sales %23.538.0 61.9%  
Current ratio x1.82.3 75.2%  
Inventory Days Days6776 87.5%  
Debtors Days Days4122 185.0%  
Net fixed assets Rs m12,6108,098 155.7%   
Share capital Rs m239230 103.8%   
"Free" reserves Rs m34,49017,088 201.8%   
Net worth Rs m35,02717,356 201.8%   
Long term debt Rs m1,2120-   
Total assets Rs m54,38725,400 214.1%  
Interest coverage x13.6311.7 4.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 98.4%   
Return on assets %13.611.8 115.8%  
Return on equity %19.217.1 112.3%  
Return on capital %24.926.9 92.3%  
Exports to sales %12.924.5 52.9%   
Imports to sales %3.128.0 11.0%   
Exports (fob) Rs m6,4615,801 111.4%   
Imports (cif) Rs m1,5406,627 23.2%   
Fx inflow Rs m6,5637,145 91.9%   
Fx outflow Rs m3,0126,846 44.0%   
Net fx Rs m3,552299 1,187.8%   
CASH FLOW
From Operations Rs m7,2593,226 225.0%  
From Investments Rs m1,864-1,555 -119.9%  
From Financial Activity Rs m-9,273-1,818 510.0%  
Net Cashflow Rs m-150-147 102.0%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 33.1 14.4 229.9%  
FIIs % 0.0 14.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 10.5 -  
Shareholders   68,381 15,184 450.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON LTD  IPCA LABS  NATCO PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 22, 2017 09:34 AM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS